Biopôle Clermont-Limagne
Technology park for life sciences
Year of creation : 2015
Statut : simplified joint stock company
Size : 1
% of CA dedicated to R&D : NC
Patents (number of) : NC

Contact details

Biopôle Clermont Limagne

2 rue Michel Renaud

63360 Saint-Beauzire



Contact : Antoine DUMEIGE
Phone : +33 682 911 005
Email : antoine.dumeige@innopain.com
Website :

Innopain

Developement of original analgesics


Innopain develops original analgesics - innovative substitutes of morphine - activators of potassium channels -TREK1. 
Activation of TREK1 allows expression of beneficial effects of morphine without expression of adverse effects.